Related Experiment Videos

Inhibition of human N-type voltage-gated Ca2+ channels by the neuroprotective agent BW619C89

N C McNaughton1, M J Leach, A H Hainsworth

  • 1Neurobiology Division, MRC Laboratory of Molecular Biology, Cambridge, UK.

Neuropharmacology
|March 28, 1998
PubMed

Insights

BW619C89 rapidly inhibits human N-type calcium channels, with faster activation kinetics observed. This state-dependent interaction suggests potential therapeutic applications for calcium channel modulation.

Area of Science:

  • Pharmacology
  • Neuroscience
  • Molecular Biology

Background:

  • N-type calcium channels play crucial roles in neurotransmitter release and neuronal excitability.
  • Dysregulation of N-type calcium channels is implicated in various neurological disorders.

Purpose of the Study:

  • To investigate the inhibitory effects of BW619C89 on human N-type calcium channels.
  • To characterize the interaction of BW619C89 with N-type calcium channels, including its potential state-dependence.

Main Methods:

  • Electrophysiological recordings (e.g., patch-clamp) were used to assess channel activity.
  • The effects of varying concentrations of BW619C89 on N-type calcium channel function were measured.
  • Activation kinetics and inhibition were analyzed at different membrane potentials.

Main Results:

  • BW619C89 demonstrated rapid and reversible inhibition of human N-type calcium channels, with an IC50 of 16.4 microM.
  • A concentration of 20 microM BW619C89 significantly accelerated channel activation kinetics.
  • The extent of inhibition was dependent on both test and holding potentials, indicating state-dependent binding.

Conclusions:

  • BW619C89 is a potent inhibitor of human N-type calcium channels.
  • The observed state-dependent interaction suggests BW619C89 may bind preferentially to specific channel conformations.
  • These findings provide insights into the mechanism of N-type calcium channel modulation by BW619C89.

Related Concept Videos